Literature DB >> 7559386

Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain.

A S Clarke1, M M Lotz, C Chao, A M Mercurio.   

Abstract

The integrin alpha 6 beta 4, a receptor for members of the laminin family of basement membrane components, contributes to the function of epithelial cells and their oncogenically transformed derivatives. In our efforts to study alpha 6 beta 4-mediated functions in more detail and to assess the contribution of the beta 4 cytoplasmic domain in such functions, we identified a rectal carcinoma cell line that lacks expression of the beta 4 integrin subunit. This cell line, termed RKO, expresses alpha 6 beta 1 but not alpha 6 beta 4, and it interacts with laminin-1 less avidly than similar cell lines that express alpha 6 beta 4. We expressed a full-length beta 4 cDNA, as well as a mutant cDNA that lacks the beta 4 cytoplasmic domain, in RKO cells and isolated stable subclones of these transfectants. In this study, we report that subclones that expressed the full-length beta 4 cDNA in association with endogenous alpha 6 exhibited partial G1 arrest and apoptosis, properties that were not evident in RKO cells transfected with either the cytoplasmic domain mutant or the expression vector alone. In an effort to define a mechanism for these observed changes in growth, we observed that expression of the alpha 6 beta 4 integrin induced expression of the p21 (WAF1; CiP1) protein, an inhibitor of cyclin-dependent kinases. These data suggest that the beta 4 integrin cytoplasmic domain is linked to a signaling pathway involved in cell cycle regulation in the beta 4 transfected RKO cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559386     DOI: 10.1074/jbc.270.39.22673

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 3.  Integrin function in breast carcinoma progression.

Authors:  L M Shaw
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

Review 4.  Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis.

Authors:  Kevin Wilhelmsen; Sandy H M Litjens; Arnoud Sonnenberg
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 6.  Integrin beta 4 in neural cells.

Authors:  Le Su; Xin Lv; Junying Miao
Journal:  Neuromolecular Med       Date:  2008-05-31       Impact factor: 3.843

Review 7.  Extracellular matrix signaling: integration of form and function in normal and malignant cells.

Authors:  N Boudreau; M J Bissell
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

8.  Integrin α6β4 in colorectal cancer.

Authors:  Jean-François Beaulieu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

Review 9.  Clinical significance of the integrin α6β4 in human malignancies.

Authors:  Rachel L Stewart; Kathleen L O'Connor
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

Review 10.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.